Validation and update of the Lémann index to measure cumulative structural bowel damage in Crohn's disease.
暂无分享,去创建一个
J. Mary | S. Sebastian | B. Barberio | B. Pariente | P. Weimers | J. Burisch | J. Colombel | K. Katsanos | D. Christodoulou | P. Ellul | A. Goldiş | R. Ungaro | N. Pedersen | J. Torres | C. Lacognata | V. Domislovic | Ž. Krznarić | J. Lambert | N. Arebi | M. Horák | P. Lung | D. Ďuricová | I. Kaimakliotis | M. Azahaf | D. M. Namara | I. Murphy
[1] S. Ng,et al. Selecting Endpoints for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT consensus from the IOIBD. , 2021, Gastroenterology.
[2] D. Altman,et al. The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS] , 2015, Journal of Crohn's & colitis.
[3] D. Altman,et al. Reliability and initial validation of the ulcerative colitis endoscopic index of severity. , 2013, Gastroenterology.
[4] E. Louis,et al. Evolving Definitions of Remission in Crohn’s Disease , 2013, Inflammatory bowel diseases.
[5] L. Peyrin-Biroulet,et al. Moving towards disease modification in inflammatory bowel disease therapy , 2013, Current opinion in gastroenterology.
[6] Jordi Rimola,et al. Magnetic resonance imaging for evaluation of Crohn's disease: Validation of parameters of severity and quantitative index of activity , 2011, Inflammatory bowel diseases.
[7] H. Tilg,et al. Development of the Crohn's disease digestive damage score, the Lémann score , 2010, Inflammatory bowel diseases.
[8] L. Peyrin-Biroulet,et al. The Natural History of Adult Crohn's Disease in Population-Based Cohorts , 2010, The American Journal of Gastroenterology.
[9] C.J.H. Mann,et al. Clinical Prediction Models: A Practical Approach to Development, Validation and Updating , 2009 .
[10] P. Rutgeerts,et al. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. , 2004, Gastrointestinal endoscopy.
[11] R. Xu. Measuring explained variation in linear mixed effects models , 2003, Statistics in medicine.
[12] Sunil J Rao,et al. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .
[13] P. Rutgeerts,et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. , 2002, Gastroenterology.
[14] V. Carey,et al. Mixed-Effects Models in S and S-Plus , 2001 .
[15] J Y Mary,et al. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). , 1989, Gut.
[16] Uma Mahadevan,et al. Inflammatory Bowel Disease 2017: Innovations and Changing Paradigms. , 2017, Gastroenterology.
[17] E. Louis,et al. Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease. , 2015, Gastroenterology.
[18] M. Picco,et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease , 2010 .
[19] Y Vergouwe,et al. Updating methods improved the performance of a clinical prediction model in new patients. , 2008, Journal of clinical epidemiology.
[20] Province,et al. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). , 1989, Gut.